UP

US approves new drug to treat Alzheimer's disease

Home page Science
12 Punto 14 Punto 16 Punto 18 Punto
US approves new drug to treat Alzheimer's disease

The US Food and Drug Administration on Friday approved a highly anticipated new drug designed to slow cognitive decline in patients in mild and early stages of Alzheimer's disease.

Axar.az reports the FDA approval of the drug, Leqembi, also known as lecanemab, comes just days after the regulatory agency was harshly criticised in a congressional report for its green-lighting of another Alzheimer's drug, Aduhelm.

And it was granted despite trial results showing the monoclonal antibody treatment carries risks of brain swelling and bleeding.

Both drugs were approved through an accelerated process that allows the FDA to fast-track approval of drugs for serious conditions where there is an unmet medical need.

Date
2023.01.07 / 11:38
Author
Axar.az
See also

Japan's Takaichi holds rare talks with Putin in Shenzhen

France confirms military personnel operating in Ukraine

Turkish, Azerbaijani FMs discuss bilateral ties

Peskov says Putin-Trump meeting will be brief

Qarabag's reserve lost 3-0 to Akas U-19 in friendly

Imamoglu sentenced to 2 years and 1 month in CHP case

British Airways plane veers off taxiway at Heathrow Airport

Gold falls to lowest price since September 2025

German foreign minister meets Pashinyan in Yerevan

Azerbaijani parliamentary delegation visits Turkmenistan

Latest
Xocalı soyqırımı — 1992-ci il Bağla
Bize yazin Bağla
ArxivBağla